C4 Therapeutics (CCCC) Net Margin (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,360.00 |
| Dec 31, 2025 | 10,156.00 |
| Sep 30, 2025 | 11,617.00 |
| Jun 30, 2025 | -3,894.00 |
| Mar 31, 2025 | 30,416.00 |
| Dec 31, 2024 | -50,725.00 |
| Sep 30, 2024 | -1,301.00 |
| Jun 30, 2024 | 78,568.00 |
| Mar 31, 2024 | 13,260.00 |
| Dec 31, 2023 | -82,165.00 |
| Sep 30, 2023 | 110,423.00 |
| Jun 30, 2023 | -42,318.00 |
| Mar 31, 2023 | 37,766.00 |
| Dec 31, 2022 | -82,974.00 |
| Sep 30, 2022 | -27,888.00 |
| Jun 30, 2022 | 21,883.00 |
| Mar 31, 2022 | -33,513.00 |
| Dec 31, 2021 | 21,240.00 |
| Sep 30, 2021 | -5,953.00 |
| Jun 30, 2021 | 5,154.00 |
| Mar 31, 2021 | -14,403.00 |
| Dec 31, 2020 | 18,183.00 |
| Sep 30, 2020 | -17,851.00 |
| Jun 30, 2020 | 6,405.00 |
| Mar 31, 2020 | -8,364.00 |
| Dec 31, 2019 | 6,608.00 |